{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:20:29Z","timestamp":1757456429126,"version":"3.40.5"},"reference-count":37,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2019,1,13]],"date-time":"2019-01-13T00:00:00Z","timestamp":1547337600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2019,1,13]],"date-time":"2019-01-13T00:00:00Z","timestamp":1547337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India","award":["JIP\/Res\/Intra-MD\/MS\/01\/2014","JIP\/Res\/Intra-MD,MS\/sec\/05\/2014"],"award-info":[{"award-number":["JIP\/Res\/Intra-MD\/MS\/01\/2014","JIP\/Res\/Intra-MD,MS\/sec\/05\/2014"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1111\/jcpt.12797","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T04:43:53Z","timestamp":1547441033000},"page":"188-196","source":"Crossref","is-referenced-by-count":14,"title":["Influence of <i>ABCB1<\/i>\n C3435T and C1236T gene polymorphisms on tumour response to docetaxel-based neo-adjuvant chemotherapy in locally advanced breast cancer patients of South India"],"prefix":"10.1155","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7934-4978","authenticated-orcid":false,"given":"Rekha","family":"Priyadarshini","sequence":"first","affiliation":[{"name":"Department of Pharmacology; Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER); Puducherry India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7499-7219","authenticated-orcid":false,"given":"Gerard Marshall","family":"Raj","sequence":"additional","affiliation":[{"name":"Department of Pharmacology; Sri Venkateshwaraa Medical College Hospital and Research Centre (SVMCH & RC); Puducherry India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7275-7377","authenticated-orcid":false,"given":"Smita","family":"Kayal","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology; Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER); Puducherry India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananthakrishnan","family":"Ramesh","sequence":"additional","affiliation":[{"name":"Department of Radio-diagnosis; Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER); Puducherry India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9993-6551","authenticated-orcid":false,"given":"Deepak Gopal","family":"Shewade","sequence":"additional","affiliation":[{"name":"Department of Pharmacology; Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER); Puducherry India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,1,13]]},"reference":[{"key":"10.1111\/jcpt.12797-BIB0001|jcpt12797-cit-0001","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1517\/17425255.2015.1008447","article-title":"Pharmacogenetics and breast cancer management: current status and perspectives","volume":"11","author":"Ciccolini","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1111\/jcpt.12797-BIB0002|jcpt12797-cit-0002","unstructured":"United States Food and Drug Administration Paving Way for Personalized Medicine: FDA's Role in a New Era of Medical Product Development [Internet] 2013 https:\/\/www.fda.gov\/downloads\/ScienceResearch\/SpecialTopics\/PersonalizedMedicine\/UCM372421.pdf"},{"key":"10.1111\/jcpt.12797-BIB0003|jcpt12797-cit-0003","first-page":"1167","volume-title":"Goodman & Gilman's Pharmacological Basis of Therapeutics","author":"Wellstein","year":"2018","edition":"13"},{"key":"10.1111\/jcpt.12797-BIB0004|jcpt12797-cit-0004","first-page":"948","volume-title":"Basic & Clinical Pharmacology","author":"Chu","year":"2018","edition":"14"},{"key":"10.1111\/jcpt.12797-BIB0005|jcpt12797-cit-0005","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4103\/0019-509X.176755","article-title":"Role of neo-adjuvant chemotherapy in locally advanced breast cancer","volume":"52","author":"Akhtar","year":"2015","journal-title":"Indian J Cancer"},{"key":"10.1111\/jcpt.12797-BIB0006|jcpt12797-cit-0006","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1200\/JCO.2007.15.0235","article-title":"Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27","volume":"26","author":"Rastogi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1111\/jcpt.12797-BIB0007|jcpt12797-cit-0007","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(17)30777-5","article-title":"Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials","volume":"19","author":"Asselain","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1111\/jcpt.12797-BIB0008|jcpt12797-cit-0008","unstructured":"NCCN Clinical Practice Guidelines in Oncology [Internet] 2017 https:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp#site"},{"key":"10.1111\/jcpt.12797-BIB0009|jcpt12797-cit-0009","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1349-7006.2006.00265.x","article-title":"Predictive factors for response to docetaxel in human breast cancers","volume":"97","author":"Noguchi","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1111\/jcpt.12797-BIB0010|jcpt12797-cit-0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2217\/pgs.13.26","article-title":"The expression profile of ATP-binding cassette transporter genes in breast carcinoma","volume":"14","author":"Hlav\u00e1\u010d","year":"2013","journal-title":"Pharmacogenomics"},{"key":"10.1111\/jcpt.12797-BIB0011|jcpt12797-cit-0011","unstructured":"PharmGKB Taxane pathway [Internet] 2016 https:\/\/www.pharmgkb.org\/pathway\/PA154426155"},{"key":"10.1111\/jcpt.12797-BIB0012|jcpt12797-cit-0012","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.2217\/pgs.12.165","article-title":"Pharmacogenetics of taxanes: impact of gene polymorphisms of drug transporters on pharmacokinetics and toxicity","volume":"13","author":"Jabir","year":"2012","journal-title":"Pharmacogenomics"},{"key":"10.1111\/jcpt.12797-BIB0013|jcpt12797-cit-0013","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/00003088-200645030-00003","article-title":"Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer","volume":"45","author":"Bosch","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12797-BIB0014|jcpt12797-cit-0014","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/PGPM.S86672","article-title":"The effect of ABCB1 polymorphisms on the outcome of breast cancer treatment","volume":"9","author":"Mittal","year":"2016","journal-title":"Pharmacogenomics Pers Med"},{"key":"10.1111\/jcpt.12797-BIB0015|jcpt12797-cit-0015","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/978-3-319-40618-3_48","volume-title":"American Joint Committee on Cancer. AJCC Cancer Staging Manual","author":"Hortobagyi","year":"2017","edition":"8"},{"key":"10.1111\/jcpt.12797-BIB0016|jcpt12797-cit-0016","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer Oxf Engl"},{"key":"10.1111\/jcpt.12797-BIB0017|jcpt12797-cit-0017","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2133\/dmpk.21.506","article-title":"Allele and genotype frequency of MDR1 C3435T in Tamilian population","volume":"21","author":"Ramasamy","year":"2006","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1111\/jcpt.12797-BIB0018|jcpt12797-cit-0018","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1089\/gtmb.2015.0077","article-title":"Association of ACE and MDR1 Gene Polymorphisms with Steroid Resistance in Children with Idiopathic Nephrotic Syndrome","volume":"19","author":"Dhandapani","year":"2015","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1111\/jcpt.12797-BIB0019|jcpt12797-cit-0019","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.canep.2013.04.012","article-title":"Influence of ABCB1 genetic variants in breast cancer treatment outcomes","volume":"37","author":"Chaturvedi","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"10.1111\/jcpt.12797-BIB0020|jcpt12797-cit-0020","first-page":"453","article-title":"Polymorphic sites (1236 and 3435) in multi drug resistance gene 1 influencing drug response in breast cancer patients","volume":"3","author":"Khan","year":"2008","journal-title":"IJP"},{"key":"10.1111\/jcpt.12797-BIB0021|jcpt12797-cit-0021","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.canep.2013.04.011","article-title":"Association of multiple drug resistance-1 gene polymorphism with multiple drug resistance in breast cancer patients from an ethnic Saudi Arabian population","volume":"37","author":"Alsaif","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"10.1111\/jcpt.12797-BIB0022|jcpt12797-cit-0022","first-page":"265","article-title":"ABCB1 (rs1128503) polymorphism and response to chemotherapy in patients with malignant tumors-evidences from a meta-analysis","volume":"8","author":"Zhou","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1111\/jcpt.12797-BIB0023|jcpt12797-cit-0023","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/cas.12560","article-title":"ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy","volume":"106","author":"Kim","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1111\/jcpt.12797-BIB0024|jcpt12797-cit-0024","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10549-013-2545-7","article-title":"Influence of ABCB1 polymorphisms and docetaxel pharmacokinetics on pathological response to neoadjuvant chemotherapy in breast cancer patients","volume":"139","author":"L\u00e9vy","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1111\/jcpt.12797-BIB0025|jcpt12797-cit-0025","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00432-012-1209-z","article-title":"Roles of ABCB1 gene polymorphisms and haplotype in susceptibility to breast carcinoma risk and clinical outcomes","volume":"138","author":"Wu","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1111\/jcpt.12797-BIB0026|jcpt12797-cit-0026","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4161\/cbt.18920","article-title":"Polymorphisms in genes involved in drug detoxification and clinical outcomes of anthracycline-based neoadjuvant chemotherapy in Chinese Han breast cancer patients","volume":"13","author":"Ji","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"10.1111\/jcpt.12797-BIB0027|jcpt12797-cit-0027","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.gene.2014.04.004","article-title":"Assessment of clinical outcomes in breast cancer patients treated with taxanes: multi-analytical approach","volume":"543","author":"Tulsyan","year":"2014","journal-title":"Gene"},{"key":"10.1111\/jcpt.12797-BIB0028|jcpt12797-cit-0028","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1007\/s11033-011-1312-2","article-title":"Lack of association between MDR1 C3435T polymorphism and chemotherapy response in advanced breast cancer patients: evidence from current studies","volume":"39","author":"Chen","year":"2012","journal-title":"Mol Biol Rep"},{"key":"10.1111\/jcpt.12797-BIB0029|jcpt12797-cit-0029","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4238\/vol7-1gmr400","article-title":"Correlation of polymorphism C3435T of the MDR-1 gene and the response of primary chemotherapy in women with locally advanced breast cancer","volume":"7","author":"Rodrigues","year":"2008","journal-title":"Genet Mol Res Gmr"},{"key":"10.1111\/jcpt.12797-BIB0030|jcpt12797-cit-0030","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.arcmed.2007.02.005","article-title":"MDR1 C3435T polymorphism in patients with breast cancer","volume":"38","author":"Turgut","year":"2007","journal-title":"Arch Med Res"},{"key":"10.1111\/jcpt.12797-BIB0031|jcpt12797-cit-0031","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3816\/CBC.2009.n.026","article-title":"A single-nucleotide polymorphism in the MDR1 gene as a predictor of response to neoadjuvant chemotherapy in breast cancer","volume":"9","author":"George","year":"2009","journal-title":"Clin Breast Cancer"},{"key":"10.1111\/jcpt.12797-BIB0032|jcpt12797-cit-0032","doi-asserted-by":"crossref","first-page":"7901","DOI":"10.1007\/s13277-015-4679-1","article-title":"Association of ABCB1 and ABCG2 single nucleotide polymorphisms with clinical findings and response to chemotherapy treatments in Kurdish patients with breast cancer","volume":"37","author":"Ghafouri","year":"2016","journal-title":"Tumor Biol"},{"key":"10.1111\/jcpt.12797-BIB0033|jcpt12797-cit-0033","first-page":"1117","article-title":"Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer","volume":"22","author":"Kafka","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1111\/jcpt.12797-BIB0034|jcpt12797-cit-0034","first-page":"187","article-title":"Polymorphism C3435T of the MDR-1 gene predict response to preoperative chemotherapy in locally advanced breast cancer with Her2\/neu expression","volume":"40","author":"Ashariati","year":"2008","journal-title":"Acta Medica Indones"},{"key":"10.1111\/jcpt.12797-BIB0035|jcpt12797-cit-0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/tpj.2009.41","article-title":"MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome","volume":"10","author":"Cizmarikova","year":"2010","journal-title":"Pharmacogenomics J"},{"key":"10.1111\/jcpt.12797-BIB0036|jcpt12797-cit-0036","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/annonc\/mdn624","article-title":"Association of the ABCB1 gene polymorphisms 2677G>T\/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients","volume":"20","author":"Chang","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1111\/jcpt.12797-BIB0037|jcpt12797-cit-0037","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.suronc.2017.09.004","article-title":"ABCB1 gene polymorphisms and response to chemotherapy in breast cancer patients: a meta-analysis","volume":"26","author":"Madrid-Paredes","year":"2017","journal-title":"Surg Oncol"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12797","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12797\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:04:02Z","timestamp":1671818642000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,13]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12797","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"type":"print","value":"0269-4727"}],"subject":[],"published":{"date-parts":[[2019,1,13]]}}}